Showing results (801-810 of 866) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|January 13, 2024
The future is on the way: β cell function preservation for type 1 diabetesJin Yang, Rui WeiMed (New York, N.Y.)|September 14, 2024
EGFR-mutated NSCLC: A roadmap to treatment sequencesNicolas GirardMed (New York, N.Y.)|September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitisQiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.Med (New York, N.Y.)|October 18, 2024
Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptorMichelle Sætersmoen, Ivan S Kotchetkov, Lamberto Torralba-Raga, et al.Med (New York, N.Y.)|October 10, 2024
Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: A prospective birth cohort studyEmma-Reetta Musakka, Maija Paula Tuulia Ylilauri, Jonna Jalanka, et al.Med (New York, N.Y.)|October 11, 2024
Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomesPaula Terroba-Navajas, Marianna Spatola, Omar Chuquisana, et al.Med (New York, N.Y.)|August 16, 2024
Bilirubin metabolism in early life and respiratory health during preschool age: A combined analysis of two independent birth cohortsMin Kim, Nicklas Brustad, Anders U Eliasen, et al.Med (New York, N.Y.)|August 16, 2024
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancerJian Pan, Junlong Wu, Beihe Wang, et al.Med (New York, N.Y.)|August 22, 2024
Accelerating drug discovery, development, and clinical trials by artificial intelligenceYilun Zhang, Mohamed Mastouri, Yang ZhangMed (New York, N.Y.)|July 31, 2024
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphomaKaiyang Ding, Hailing Liu, Haiyan Yang, et al.Pageof 87